Blood transfusion is the process of adding blood into the body after a serious injury or illness. The process of blood transfusion is carried out by placing a venous access device and catheter into either a peripheral or central vein or passing the blood or blood component through an infusion pump or apheresis systems.
The blood transfusion process has wide applications in the treatment of various medical conditions such as blood disorders, autoimmune disorders, cancer, renal disorders, surgical procedures, and others.
Market Dynamics
The global blood transfusion devices market is expected to witness significant growth during the forecast period, owing to increasing number of accidents. Accidents result in severe blood loss, which increases demand for blood transfusion. For instance, according to the World Health Organization (WHO) 2020, approximately 1.35 million people die each year due to road accidents, and between 20 and 50 million people suffer from non-fatal injuries, globally.
Key features of the study:
Detailed Segmentation:
Global Blood Transfusion Devices Market, By Product Type:
Global Blood Transfusion Devices Market, By End User:
Global Blood Transfusion Devices Market, By Region:
Company Profiles
“*” marked represents similar segmentation in other categories in the respective section.
The blood transfusion process has wide applications in the treatment of various medical conditions such as blood disorders, autoimmune disorders, cancer, renal disorders, surgical procedures, and others.
Market Dynamics
The global blood transfusion devices market is expected to witness significant growth during the forecast period, owing to increasing number of accidents. Accidents result in severe blood loss, which increases demand for blood transfusion. For instance, according to the World Health Organization (WHO) 2020, approximately 1.35 million people die each year due to road accidents, and between 20 and 50 million people suffer from non-fatal injuries, globally.
Key features of the study:
- This report provides in-depth analysis of the global blood transfusion devices market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
- It profiles key players in the global blood transfusion devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include Fresenius Kabi AG, Grifols, S.A., Tenko International Group Corp, Terumo Corporation, Kawasumi Laboratories, Inc., Haemonetics Corporation, Bioelectronica MILANO, RAYS S.P.A., Macopharma SA, B. Braun Melsungen AG, Baxter International Inc., Neomedic Limited, and 3M Company
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, government initiatives, technological upgradation, market expansion, and marketing tactics
- The global blood transfusion devices market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers in the blood transfusion devices market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Global Blood Transfusion Devices Market, By Product Type:
- Apheresis Systems
- Infusion Devices
- Blood Warmers
- Venous Access Devices
- Filters
- Others
Global Blood Transfusion Devices Market, By End User:
- Hospital
- Ambulatory Surgical Centers
- Others
Global Blood Transfusion Devices Market, By Region:
- North America
- By Country
- U.S.
- Canada
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country/Region
- South Africa
- Central Africa
- North Africa
Company Profiles
- Fresenius Kabi AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Grifols, S.A.
- Tenko International Group Corp
- Terumo Corporation
- Kawasumi Laboratories, Inc.
- Haemonetics Corporation
- Bioelectronica MILANO
- RAYS S.P.A.
- Macopharma SA
- B. Braun Melsungen AG
- Baxter International Inc.
- Neomedic Limited
- 3M Company
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
2. Market Overview
3. Market Dynamics, Regulations, and Trends Analysis
4. Impact Analysis of Covid-19
5. Global Blood Transfusion Devices Market, By Product Type, 2016 - 2027, (US$ Million)
6. Global Blood Transfusion Devices Market, By End User, 2016 - 2027, (US$ Million)
7. Global Blood Transfusion Devices Market, By Region, 2016 - 2027, (US$ Million)
8. Competitive Landscape
9. Section
Companies Mentioned
A selection of companies mentioned in this report includes:
- Fresenius Kabi AG
- Grifols, S.A.
- Tenko International Group Corp
- Terumo Corporation
- Kawasumi Laboratories, Inc.
- Haemonetics Corporation
- Bioelectronica MILANO
- RAYS S.P.A.
- Macopharma SA
- B. Braun Melsungen AG
- Baxter International Inc.
- Neomedic Limited
- 3M Company
